Wan, Vincent
Silverberg, Jonathan I.
Funding for this research was provided by:
Galderma (N/A)
Dermatology Foundation (CDA)
Agency for Healthcare Research and Quality (K12 HS023011)
Article History
Received: 20 November 2023
Revised: 20 November 2023
Accepted: 7 April 2024
First Online: 11 May 2024
Declarations
:
: J. I. Silverberg is advisor, speaker, and/or consultant for AbbVie, Asana Biosciences, Dermavant, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, LEO Pharma, Lilly, Menlo Therapeutics, Novartis, Pfizer, Realm Pharma, and Regeneron-Sanofi. He is also a researcher for GlaxoSmithKline.
: Reviewed and approved by George Washington University
: Not applicable